In the current project, we developed an in silico approach to identify lncRNAs, which are functionally associated with FOXM1, GATA3, FOXA1 and ESR1. Subsequently, we validated the results of in silico methods in clinical samples and assessed the expression of these genes and five lncRNAs in breast cancer samples and ANCTs. This evidence concerns the gene FOXA1 and breast cancer.